(Q44387038)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12670564%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Neoadjuvant docetaxel and estramustine chemotherapy in high-risk/locally advanced prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12670564%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

1 reference

1 reference

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12670564%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Joseph Fontana

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12670564%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

Maha Hussain

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12670564%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Basil F El-Rayes

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12670564%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Wei Du

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12670564%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Ulka Vaishampayan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12670564%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Wael Sakr

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12670564%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

David Wood

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12670564%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

English

0 references

publication date

1 April 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12670564%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12670564%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12670564%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12670564%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

774-780

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12670564%20AND%20SRC:MED&resulttype=core&format=json

Adjuvant and neoadjuvant therapy in prostate cancer.

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902519-0

7 January 2021

The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902519-0

7 January 2021

Postoperative radiotherapy for stage pT3 carcinoma of the prostate: improved local control

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902519-0

7 January 2021

Natural history of progression after PSA elevation following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902519-0

7 January 2021

Randomized, prospective, controlled study comparing radical prostatectomy alone and neoadjuvant androgen withdrawal in the treatment of localized prostate cancer. Canadian Urologic Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902519-0

7 January 2021

4-Year follow-up results of a European prospective randomized study on neoadjuvant hormonal therapy prior to radical prostatectomy in T2-3N0M0 prostate cancer. European Study Group on Neoadjuvant Treatment of Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902519-0

7 January 2021

Neoadjuvant estramustine and etoposide followed by concurrent estramustine and definitive radiotherapy for locally advanced prostate cancer: feasibility and preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902519-0

7 January 2021

Phase II trial of neoadjuvant estramustine and etoposide plus radical prostatectomy for locally advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902519-0

7 January 2021

Neoadjuvant chemotherapy and hormonal therapy followed by radical prostatectomy: feasibility and preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902519-0

7 January 2021

Results of a phase II study using estramustine phosphate and vinblastine in combination with high-dose three-dimensional conformal radiotherapy for patients with locally advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902519-0

7 January 2021

Phase II study of docetaxel, estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: a final report of CALGB 9780. Cancer and Leukemia Group B.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902519-0

7 January 2021

One-sample multiple testing procedure for phase II clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902519-0

7 January 2021

Preliminary observations of single-agent docetaxel as neoadjuvant therapy for locally advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902519-0

7 January 2021

Neoadjuvant docetaxel followed by radical prostatectomy in patients with high-risk localized prostate cancer: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902519-0

7 January 2021

Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902519-0

7 January 2021

The prostate: MR imaging and spectroscopy. Present and future

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902519-0

7 January 2021

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2902519-0

7 January 2021

10.1016/S0090-4295(02)02519-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12670564%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference